Jonathan Lim
Impact in
-
- Venous Thromboembolism Diagnosis and Management
Papers in
- Oncology 8
- PARP inhibition in cancer therapy 7
- Colorectal Cancer Treatments and Studies 1
-
- Ovarian cancer diagnosis and treatment 7
- Co-authors
- Stephen Sander (5 shared papers)Jason Swindle (1 shared paper)Cheng Wang (1 shared paper)Tim Bancroft (1 shared paper)Anna F. Farago (1 shared paper)Alice T. Shaw (1 shared paper)Zachary Hornby (1 shared paper)Sai‐Hong Ignatius Ou (1 shared paper)
- Journals
- Future Oncology (2 papers)Journal of Managed Care & Specialty Pharmacy (2 papers)Cancer (1 paper)International Journal of Gynecological Cancer (1 paper)BMC Pulmonary Medicine (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Jonathan Lim
13 papers receiving 134 citations
Peers
Comparison fields: 5 of 37
- Internal Medicine 16
- Family Practice 5
- Cardiology and Cardiovascular Medicine 49
- Pulmonary and Respiratory Medicine 67
- Economics and Econometrics 36
Countries citing papers authored by Jonathan Lim
This map shows the geographic impact of Jonathan Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Lim more than expected).
Fields of papers citing papers by Jonathan Lim
This network shows the impact of papers produced by Jonathan Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Lim. The network helps show where Jonathan Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 36 | |
| 2 | 2016 | 25 | |
| 3 | 2014 | 19 | |
| 4 | 2016 | 17 | |
| 5 | 2020 | 10 | |
| 6 | 2018 | 7 | |
| 7 | 2019 | 6 | |
| 8 | 2017 | 5 | |
| 9 | 2019 | 4 | |
| 10 | 2021 | 4 | |
| 11 | 2014 | 2 | |
| 12 | 2023 | 1 | |
| 13 | 2015 | 1 | |
| 14 | 2025 | 0 | |
| 15 | 2025 | 0 | |
| 16 | 2025 | 0 | |
| 17 | 2024 | 0 | |
| 18 | 2024 | 0 | |
| 19 | 2024 | 0 | |
| 20 | 2025 | 0 |
About Jonathan Lim
Jonathan Lim is a scholar working on Oncology, Reproductive Medicine, Pulmonary and Respiratory Medicine, Economics and Econometrics and Cardiology and Cardiovascular Medicine, having authored 20 papers that have together received 137 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (7 papers), Ovarian cancer diagnosis and treatment (7 papers), Atrial Fibrillation Management and Outcomes (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Lung Cancer Treatments and Mutations (4 papers), Gastric Cancer Management and Outcomes (3 papers), Economic and Financial Impacts of Cancer (2 papers) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Internal Medicine (16 citations), Family Practice (5 citations), Cardiology and Cardiovascular Medicine (49 citations), Pulmonary and Respiratory Medicine (67 citations) and Economics and Econometrics (36 citations). Jonathan Lim has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Stephen Sander, Jason Swindle, Cheng Wang, Tim Bancroft, Anna F. Farago, Alice T. Shaw, Zachary Hornby, Sai‐Hong Ignatius Ou, Todd M. Bauer and Alexander Drilon. Their work appears in journals such as Future Oncology, Journal of Managed Care & Specialty Pharmacy, Cancer, International Journal of Gynecological Cancer and BMC Pulmonary Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.